No Data
Senseonics Kicks Off $50 Million Stock Offering; Discloses Private Placement of Up to $25 Million With Abbott Laboratories
Abbott Laboratories Stock Advances 3.7%, Outperforms Competitors
Abbott Laboratories Shares Are Trading Higher After the Company Announced Its REFLECT Real-world Studies Showed Positive Results in the Reduction of Risk for Heart Complications for People With Diabetes.
Unusual Options Activity: ABT, RBLX and Others Attract Market Bets, ABT V/OI Ratio Reaches 125.0
EST May 15th Morning Delivery - In the last two hours of trading, 8 options with a high V/OI ratio were detected. With the market volatile, it's crucial to stay informed on the latest options trends.
Express News | Abbott Shares up 3% as Co's Device Helps Reduce Hospitalizations
Express News | Abbott's Libre® Technology Is First Continuous Glucose Monitor Associated With Reduced Hospitalizations for Heart Complications in People With Diabetes
